West Pharmaceutical Services Inc at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 03:00PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research

Good morning, everyone. Welcome to the last day of Bank of America's 2023 Healthcare Conference. And just happy everybody here, coming to you live from the Encore here in Las Vegas. I'm Derik De Bruin. And along with my colleague, Mike Ryskin, we're the Life Sciences and Diagnostics Tools team. And to kick off our conversation this morning is West Pharmaceutical Services. With us from West is Bernard Birkett, Senior Vice President and CFO; and Quintin Lai from Head of IR and also VP.

Gentlemen, welcome. Thanks for being here. Thanks for making it out. And Quintin, I know you just got in from -- you flew in all the way from Dublin to be here. So I appreciate that. You're still on your feet. So thanks for that.

Questions and Answers:

Derik De Bruin - BofA Securities, Research Division - MD of Equity Research

So let's start with discussing some of the points in your first quarter. Surprising mix, your 2.3% organic growth overall; proprietary products, flat; your CMO, up 14%
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot